GSK Plc has halted development of its herpes simplex virus vaccine, GSK3943104, after it failed to meet efficacy goals in ...

The words hit me like a punch in the stomach. I felt all the blood drain from my face and the air seep out of my lungs. Until ...

GSK’s attempt to develop the first vaccine for herpes simplex virus (HSV) has ended in failure, leaving the race open for the ...

British drugmaker GSK said on Wednesday its experimental herpes simplex virus (HSV) vaccine candidate failed to meet the main ...

A cobblestone throat occurs when inflamed bumps develop in the back of your throat. Infections, allergies, and acid reflux ...

Without revealing specific details, GSK announced that it is terminating the development of its investigational herpes ...

GSK Plc’s experimental vaccine for herpes failed in an early-stage trial, halting an effort to bring the first shot for the ...

GSK has announced that Part II of the Phase I/II TH HSV REC-003 trial of its therapeutic herpes simplex virus (HSV) vaccine candidate, GSK3943104, did not meet its primary efficacy endpoint. The ...

GSK's HSV vaccine candidate fails mid-stage trial, will not progress to late-stage trial. No safety concerns observed.

A study investigating GSK’s investigational herpes simplex virus (HSV) vaccine candidate failed to meet its primary efficacy endpoint.